跳至主要内容
临床试验/CTRI/2022/03/041210
CTRI/2022/03/041210已完成未知

To compare the efficacy of broad-spectrum antibiotics with or without rifaximin in the treatment of acute hepatic encephalopathy in critically ill patients - A double blind, randomized controlled trial - ARiE trial

AIG Hospitals0 个研究点目标入组 184 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
AIG Hospitals
入组人数
184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • liver disease patients admitted to the high dependency unit or intensive care unit above the age of 18 with a primary diagnosis of hepatic encephalopathy irrespective of the precipitant.

排除标准

  • acute liver failure
  • other causes of encephalopathy (ex: uremic encephalopathy - S. urea > 150)
  • patients with underlying chronic renal failure
  • patients on antidepressants or sedatives
  • underlying neuropsychiatric conditions
  • history of alcohol consumption of less than one week
  • patients who died within 24 hours of admission
  • patients who refused to participate in the study
  • patients below the age of 18

研究者

发起方
AIG Hospitals

相似试验